Erika Carmel Ltd Cash Flow Conversion Efficiency
Erika Carmel Ltd cash flow conversion efficiency. Based on the latest financial reports, Erika Carmel Ltd (BCUR) has a cash flow conversion efficiency ratio of 0.113x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA1.52 Million ≈ $4.07K USD) by net assets (ILA13.40 Million ≈ $35.92K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Erika Carmel Ltd (2019–2024)
Cash flow conversion efficiency of Erika Carmel Ltd from 2019 to 2024. This chart illustrates how Erika Carmel Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View BCUR share price today for real-time trading data and today's change.
Erika Carmel Ltd Cash Flow Conversion Ratio Explained
Erika Carmel Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Erika Carmel Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Erika Carmel Ltd ranked by their cash flow conversion efficiency. Also see Erika Carmel Ltd market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Genesis Resources Ltd
AU:GES
|
-0.764x |
|
THREED CAPITAL INC.
F:B5K3
|
N/A |
|
Oncozenge AB
ST:ONCOZ
|
12.336x |
|
Wira Global Solusi Tbk PT
JK:WGSH
|
0.021x |
|
TaoWeave Inc.
NASDAQ:TWAV
|
-0.098x |
|
Braster S.A.
WAR:BRA
|
-0.048x |
|
MAST ENERGY DEV. LS -001
F:97D
|
N/A |
|
Zonte Metals Inc
V:ZON
|
0.000x |
Annual Cash Flow Conversion Efficiency for Erika Carmel Ltd (2019–2024)
The table below shows the annual cash flow conversion efficiency of Erika Carmel Ltd from 2019 to 2024. Review Erika Carmel Ltd (BCUR) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ILA15.04 Million ≈ $40.31K |
ILA-4.22 Million ≈ $-11.33K |
-0.281x | +25.70% |
| 2023-12-31 | ILA23.73 Million ≈ $63.61K |
ILA-8.97 Million ≈ $-24.06K |
-0.378x | +52.26% |
| 2022-12-31 | ILA42.67 Million ≈ $114.39K |
ILA-33.80 Million ≈ $-90.61K |
-0.792x | -142.64% |
| 2021-12-31 | ILA88.06 Million ≈ $236.09K |
ILA-28.75 Million ≈ $-77.08K |
-0.326x | -116.08% |
| 2020-12-31 | ILA8.97 Million ≈ $24.05K |
ILA18.21 Million ≈ $48.81K |
2.030x | +11.65% |
| 2019-12-31 | ILA3.11 Million ≈ $8.33K |
ILA5.65 Million ≈ $15.14K |
1.818x | -- |
About Erika Carmel Ltd
Erika B-Cure Laser Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. It offers B-Cure Laser Classic, a home medical device for the treatment of pain, orthopedic problems, dermatology, analgesia, inflammation, and wound healing; and B-Cure Laser Pro, a device for the treatment of acute and chronic problems, such as orthopedic probl… Read more